As of 2025-07-04, the Net Margin of Abcellera Biologics Inc (ABCL) is -564.8%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -564.8% |
2023-12-31 | -385% |
2022-12-31 | 32.7% |
2021-12-31 | 40.9% |
2020-12-31 | 51% |
2019-12-31 | -19% |
2018-12-31 | 3.4% |
- | |
- | |
- |